Skip to main content
. 2020 Dec 14;40(12):BSR20201006. doi: 10.1042/BSR20201006

Table 1. Clinical information of breast cancer patients.

Number Age Gender IHC TNM stage Pathological diagnosis
477111 68 Female ER (+ +), PR (+ +), Her-2 (1+), TOPI-II (+/-), E-Cad (++), CK-L (++), CD56 (-), CgA (-), SYN (-), Ki-67 (+, 3%) T3 N1 M1 Invasive ductal breast carcinoma (II)
460482 40 Female ER (+ +), PR (+ +), Her-2 (2+), TOPI-II (+, 8%), E-Cad (+), P120 (+), Ki-67 (+, 7%) T3 N1 M1 Invasive ductal breast carcinoma (III)
470667 44 Female ER (+ +), PR (+ +), Her-2 (2+), CK5/6 (-), SMA (+), calponin (+), p63 (+), CD10 (+), Ki-67 (+, 20%) T1 N0 M0 Papillary carcinoma
465297 49 Female ER (+ +), PR (+ +), Her-2 (0), TOPI-II (+, 3%), E-Cad (++), P120 (++), Ki-67 (+, 10%) T2 N1 M0 Invasive ductal breast carcinoma (II)
465298 41 Female ER (+ +), PR (+ +), Her-2 (1+), TOPI-II (+, 2%), E-Cad (++), P120 (++), Ki-67 (+, 4%) T2 N1 M0 Invasive ductal breast carcinoma (II)
470354 31 Female ER (+, 50%), PR (+, 30%), Her-2 (3+), TOPI-II (+, 10%), Ki-67 (+, 60%) T2 N0 M0 Invasive ductal breast carcinoma (III)